Shionogi Crescita futura
Future criteri di controllo 0/6
Informazioni chiave
-0.3%
Tasso di crescita degli utili
1.3%
Tasso di crescita dell'EPS
Pharmaceuticals crescita degli utili | 17.9% |
Tasso di crescita dei ricavi | 1.0% |
Rendimento futuro del capitale proprio | 10.7% |
Copertura analitica | Good |
Ultimo aggiornamento | 29 Oct 2024 |
Aggiornamenti recenti sulla crescita futura
Recent updates
Previsioni di crescita degli utili e dei ricavi
Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
---|---|---|---|---|---|
3/31/2027 | 470,833 | 167,396 | 170,857 | 196,298 | 12 |
3/31/2026 | 450,383 | 158,312 | 155,949 | 184,842 | 13 |
3/31/2025 | 455,589 | 163,338 | 165,072 | 190,736 | 3 |
9/30/2024 | 443,518 | 154,570 | 133,101 | 187,548 | N/A |
6/30/2024 | 423,356 | 150,105 | 102,435 | 156,400 | N/A |
3/31/2024 | 435,081 | 162,030 | 126,017 | 154,284 | N/A |
12/31/2023 | 425,157 | 154,458 | 104,561 | 128,536 | N/A |
9/30/2023 | 506,446 | 218,294 | 147,126 | 165,030 | N/A |
6/30/2023 | 464,156 | 192,805 | 145,825 | 171,002 | N/A |
3/31/2023 | 426,684 | 184,965 | 140,680 | 177,867 | N/A |
12/31/2022 | 453,859 | 200,914 | 97,163 | 141,746 | N/A |
9/30/2022 | 340,832 | 118,318 | 51,961 | 105,430 | N/A |
6/30/2022 | 338,012 | 116,669 | 72,156 | 120,051 | N/A |
3/31/2022 | 335,138 | 114,185 | 70,504 | 102,068 | N/A |
12/31/2021 | 292,384 | 96,785 | 87,101 | 127,108 | N/A |
9/30/2021 | 293,810 | 115,608 | 82,351 | 117,069 | N/A |
6/30/2021 | 294,740 | 122,560 | 83,364 | 115,020 | N/A |
3/31/2021 | 297,177 | 111,858 | 76,095 | 109,039 | N/A |
12/31/2020 | 304,276 | 117,422 | N/A | N/A | N/A |
9/30/2020 | 320,946 | 119,958 | 105,372 | 117,777 | N/A |
6/30/2020 | 325,548 | 119,311 | N/A | N/A | N/A |
3/31/2020 | 333,371 | 122,193 | 120,172 | 131,940 | N/A |
12/31/2019 | 351,993 | 129,259 | N/A | N/A | N/A |
9/30/2019 | 356,395 | 126,479 | 127,199 | 138,629 | N/A |
6/30/2019 | 354,422 | 125,285 | N/A | N/A | N/A |
3/31/2019 | 363,721 | 132,759 | 136,560 | 145,684 | N/A |
12/31/2018 | 346,547 | 123,483 | N/A | N/A | N/A |
9/30/2018 | 340,698 | 116,426 | 147,122 | 155,169 | N/A |
6/30/2018 | 358,168 | 124,748 | N/A | N/A | N/A |
3/31/2018 | 344,667 | 108,866 | N/A | 129,790 | N/A |
12/31/2017 | 345,719 | 96,065 | N/A | N/A | N/A |
9/30/2017 | 355,961 | 103,017 | N/A | 109,944 | N/A |
6/30/2017 | 340,755 | 87,353 | N/A | N/A | N/A |
3/31/2017 | 338,890 | 83,879 | N/A | 111,903 | N/A |
12/31/2016 | 340,583 | 92,559 | N/A | N/A | N/A |
9/30/2016 | 326,795 | 76,499 | N/A | 105,915 | N/A |
6/30/2016 | 319,268 | 69,566 | N/A | N/A | N/A |
3/31/2016 | 309,973 | 66,687 | N/A | 102,290 | N/A |
12/31/2015 | 299,645 | 59,468 | N/A | N/A | N/A |
9/30/2015 | 282,428 | 55,736 | N/A | 64,409 | N/A |
6/30/2015 | 275,117 | 43,395 | N/A | N/A | N/A |
3/31/2015 | 273,991 | 44,060 | N/A | 45,604 | N/A |
12/31/2014 | 271,887 | 30,857 | N/A | N/A | N/A |
9/30/2014 | 280,844 | 30,136 | N/A | 61,135 | N/A |
6/30/2014 | 285,189 | 41,307 | N/A | N/A | N/A |
3/31/2014 | 289,717 | 41,831 | N/A | 79,496 | N/A |
12/31/2013 | 289,559 | 75,622 | N/A | N/A | N/A |